Microchip Biotechnologies | GenomeWeb

Microchip Biotechnologies

Paired Ends

Premium

Debi Frost, Stan Lapidus

Paired Ends

Premium

Karen Nelson, Bob Strausberg, Howard Goldstein, Sidney Stolz, Andrew Last

The company plans to use the funding to commercialize its Apollo 100 system, a sample-preparation system for Sanger sequencing, and to develop the Apollo platform for the next-generation sequencing markets as well as for DNA-based human identification and forensics.

Paired Ends

Premium

Eric Green, Chung-Fan Chiou, Hubert Renauld, Jim Blair, Bill Byun

People in the News

Gladstone Institutes name Bruce Spaulding as chief of planning strategy; Bruker's Dirk Laukien resigns as William Knight and Brian Monahan promoted; plus more.

MBI plans to use the series B venture funding to develop its Apollo sample prep technologies.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.